Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Washington University (WashU) in St. Louis, Missouri, USA. The agreement marks the next chapter in a nearly century-long partnership dedicated to advancing scientific research and innovation. The expanded collaboration will support joint research initiatives, technology scouting, and research enablement, with an emphasis on fostering sustainable and socially responsible scientific progress...

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand. A new dedicated AI in Safety & PV Community of Experts (CoE) will explore how to apply AI safely, ethically and effectively within pharmacovigilance workflows...

A well-established EMBL partner, Boehringer Ingelheim Stiftung (BIS), is providing €7 million to continue the successful development of the EMBL Imaging Centre (IC). Since its inception, the highly committed staff have positioned the EMBL IC as an internationally leading institution for cutting-edge imaging technologies. This is already the second round of funding by BIS, enabling EMBL to maintain and recruit additional highly qualified staff members...

Alpha Laboratories Ltd has been acquired by Diploma PLC, a FTSE 100 UK-listed group specialising in value-added technical products and services across Life Sciences, Seals, and Controls. Diploma adds value by providing essential products and solutions through a decentralised, customer-orientated approach within each of its end markets...

Thermo Fisher Scientific Inc., the world leader in serving science, and the South African Medical Research Council (SAMRC), an entity of the Department of Health, together with South Africa’s  Department of Science Innovation and Technology, have announced the official opening of a dedicated training facility for advanced molecular science and laboratory management to further enhance essential scientific skills in-country, supporting future pandemic preparedness and local health system resilience...

The UK’s largest gathering for laboratory professionals returns to the NEC, Birmingham, on 29 and 30 October 2025, bringing together thousands from across the scientific community. Lab Innovations 2025 will highlight sustainability initiatives, the latest in lab technology and a renewed focus on collaboration, with more than 200 suppliers exhibiting to an audience of researchers, technicians and science professionals...

An entrepreneur who founded one of the UK’s leading biotechnology companies has launched a new venture that aims to transform laboratory data management. Ryan Cawood, who founded OXGENE, has raised £750,000 from the Midlands Engine Investment Fund II, through fund manager Mercia Ventures, for his latest business, Lab Thread...

Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom...

Optibrium, a leading developer of software and AI solutions for molecular design, has announced it has secured a strategic financing package with Shawbrook, a specialist UK bank that provides finance to established UK businesses on high growth trajectories. This multi-million-pound deal will enable Optibrium to continue to build its offering to global pharmaceutical and biotech teams, further increasing the speed and efficiency of their drug discovery timelines...

Thermo Fisher Scientific has announced that U.S. Food and Drug Administration (FDA) has approved the Oncomine™ Dx Express Test on the Ion Torrent™ Genexus™ Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay for use as a companion diagnostic (CDx) for Dizal’s ZEGFROVY® (sunvozertinib) and in tumor profiling. This approval brings rapid next-generation sequencing (NGS) to decentralized clinical settings closer to where patients receive care...

In early July, Carl Zeiss Microscopy GmbH has acquired all equity shares of Pi Imaging Technology SA, based in Lausanne, Switzerland. Pi Imaging Technology SA now operates as "Pi Imaging Technology SA – a ZEISS company". The Lausanne location with all employees will be retained.  Pi Imaging Technology SA has been a trusted partner of ZEISS Research Microscopy Solutions for many years...

This year, the Hamburg based life sicences company Eppendorf SE is awarding its prestigious research prize for the 30th time. The independent jury chaired by Prof. Laura Machesky, Cambridge, UK, selected Dr. Varun Venkataramani, Heidelberg University Hospital, Germany as the winner of the Eppendorf Award for Young European Investigators 2025. Varun Venkataramani receives the 20,000 Euro award for his research on...

SPT Labtech, a global leader in innovative laboratory automation, has announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs. The partnership will integrate SPT Labtech’s firefly® liquid handling platform with Semarion’s SemaCyte® microcarrier technology to develop a flexible, scalable, and automated workflow...

HORIBA, a global leader in analytical and measurement technology, has expanded its worldwide network of Analytical Solution Plazas with the opening in the UK of its latest advanced technology centre. Sited in the centre of the country on MIRA Tech Park, the HORIBA Group’s new customer and scientific collaboration site was opened by HORIBA Group CEO, Mr. Atsushi Horiba, and British Ambassador to Japan, Her Excellency Ms Julia Longbottom CMG...

The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO Group AB, as announced in April. The acquisition was completed on July 1, 2025, following the receipt of the required regulatory approval and the fulfillment of other customary closing conditions. With the integration of the business into its Lab Products and Services division, Sartorius is expanding its cell technology portfolio...

GenNext® Technologies, Inc., a pioneer in protein footprinting, is collaborating with Thermo Fisher Scientific, the world leader in serving science, to provide a simplified structural biology workflow designed to improve biotherapeutic development. The organizations are combining GenNext’s AutoFox® Protein Footprinting System with Thermo Fisher’s industry-leading liquid chromatography-mass spectrometry (LC-MS) solutions...

Figures show that the UK produces 3 million tonnes of hazardous waste every year. With 15% of healthcare sector waste classed as hazardous, the cumulative impact can be substantial when waste isn't managed properly. Mismanagement of hazardous, contaminated, or expired materials can lead to health risks, environmental harm, and even legal consequences. As a result, the safe disposal of laboratory waste is crucial for protecting your local area...

Waters Corporation and BD (Becton, Dickinson and Company) has announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, creating an innovative life science and diagnostics leader with pioneering technologies and an industry-leading financial outlook. The agreement is structured as a tax-efficient Reverse Morris Trust transaction valued at approximately $17.5 billion...

Alphalyse, a fast-growing Danish specialist contract research organization (CRO) that has developed GMP‑validated liquid‑chromatography mass‑spectrometry (LC‑MS) assays for host‑cell‑protein (HCP) impurity testing in biologic drugs, announces that Fidelio Capital has acquired a majority stake in the company. Alphalyse’s founders will retain a significant shareholding, establishing an ambitious partnership aimed at expanding capacity, accelerating international growth...